Literature DB >> 33833368

Identification of chlorophyll a-b binding protein AB96 as a novel TGFβ1 neutralizing agent.

Steven Lynham1, Fabio Grundland Freile2, Natasha M Puri2, Nicola O'Reilly3, Graham H Mitchell4, Timothy N C Wells5, Merlin Willcox6, Richard Beatson7.   

Abstract

The discovery of compounds and proteins from plants has greatly contributed to modern medicine. Vernonia amygdalina Del. (Compositae) is used by humans and primates for a variety of conditions including parasitic infection. This paper describes the serendipitous discovery that V. amygdalina extract was able to bind to, and functionally inhibit, active TGFβ1. The binding agent was isolated and identified as chlorophyll a-b binding protein AB96. Given that active TGFβ1 contributes to the pathology of many infectious diseases, inhibiting these processes may explain some of the benefits associated with the ingestion of this species. This is the first plant-derived cytokine-neutralizing protein to be described and paves the way for further such discoveries.

Entities:  

Year:  2021        PMID: 33833368     DOI: 10.1038/s41598-021-87454-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  25 in total

1.  In vivo antimalarial activity of Vernonia amygdalina.

Authors:  Anthonia O Abosi; Benjamin H Raseroka
Journal:  Br J Biomed Sci       Date:  2003       Impact factor: 3.829

Review 2.  TGF-beta: a mobile purveyor of immune privilege.

Authors:  Sharon M Wahl; Jie Wen; Niki Moutsopoulos
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

3.  The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina.

Authors:  Anoka A Njan; Bulus Adzu; Amon G Agaba; Dominic Byarugaba; Silvia Díaz-Llera; David R Bangsberg
Journal:  J Med Food       Date:  2008-09       Impact factor: 2.786

Review 4.  Making sense of latent TGFbeta activation.

Authors:  Justin P Annes; John S Munger; Daniel B Rifkin
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

5.  Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains.

Authors:  B A Iwalokun
Journal:  Afr Health Sci       Date:  2008-03       Impact factor: 0.927

6.  A clinical trial of the traditional medicine Vernonia amygdalina in the treatment of uncomplicated malaria.

Authors:  Simon Challand; Merlin Willcox
Journal:  J Altern Complement Med       Date:  2009-11       Impact factor: 2.579

Review 7.  A review of the medicinal potentials of plants of the genus Vernonia (Asteraceae).

Authors:  Ngeh J Toyang; Rob Verpoorte
Journal:  J Ethnopharmacol       Date:  2013-02-08       Impact factor: 4.360

8.  Toward the chemical ecology of medicinal plant use in chimpanzees: The case ofVernonia amygdalina, a plant used by wild chimpanzees possibly for parasite-related diseases.

Authors:  H Ohigashi; M A Huffman; D Izutsu; K Koshimizu; M Kawanaka; H Sugiyama; G C Kirby; D C Warhurst; D Allen; C W Wright; J David Phillipson; P Timon-David; F Delmas; R Elias; G Balansard
Journal:  J Chem Ecol       Date:  1994-03       Impact factor: 2.626

Review 9.  Natural products as starting points for future anti-malarial therapies: going back to our roots?

Authors:  Timothy N C Wells
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

10.  Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule.

Authors:  Fakhreldin M Omer; J Brian de Souza; Patrick H Corran; Ali A Sultan; Eleanor M Riley
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.